Albemarle Corporation (NYSE:ALB – Get Free Report) has been given a consensus recommendation of “Hold” by the twenty-one analysts that are covering the stock, Marketbeat Ratings reports. Three analysts have rated the stock with a sell recommendation, thirteen have issued a hold recommendation and five have given a buy recommendation to the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $91.29.
Several equities research analysts have recently issued reports on the company. Wall Street Zen raised Albemarle to a “sell” rating in a research note on Monday, May 5th. Morgan Stanley decreased their price target on Albemarle from $68.00 to $58.00 and set an “underweight” rating for the company in a research note on Tuesday, May 6th. TD Securities decreased their price target on Albemarle from $115.00 to $65.00 and set a “hold” rating for the company in a research note on Thursday, May 1st. Truist Financial decreased their price target on Albemarle from $85.00 to $65.00 and set a “hold” rating for the company in a research note on Monday, April 14th. Finally, Piper Sandler set a $68.00 price target on Albemarle and gave the stock an “underweight” rating in a research note on Wednesday, May 14th.
Institutional Inflows and Outflows
Albemarle Price Performance
NYSE:ALB opened at $71.07 on Friday. The firm has a market capitalization of $8.36 billion, a price-to-earnings ratio of -6.39 and a beta of 1.63. Albemarle has a 1 year low of $49.43 and a 1 year high of $113.91. The business has a 50 day simple moving average of $61.18 and a 200-day simple moving average of $70.49. The company has a debt-to-equity ratio of 0.39, a current ratio of 2.11 and a quick ratio of 1.26.
Albemarle (NYSE:ALB – Get Free Report) last posted its quarterly earnings data on Wednesday, April 30th. The specialty chemicals company reported ($0.18) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.62) by $0.44. The business had revenue of $1.08 billion during the quarter, compared to analyst estimates of $1.18 billion. Albemarle had a negative return on equity of 1.92% and a negative net margin of 22.39%. The company’s revenue for the quarter was down 20.9% on a year-over-year basis. During the same period last year, the company earned $0.26 EPS. Equities analysts forecast that Albemarle will post -0.04 EPS for the current year.
Albemarle Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Tuesday, July 1st. Stockholders of record on Friday, June 13th were issued a $0.405 dividend. The ex-dividend date was Friday, June 13th. This represents a $1.62 dividend on an annualized basis and a dividend yield of 2.28%. Albemarle’s dividend payout ratio is presently -14.57%.
About Albemarle
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.
Read More
- Five stocks we like better than Albemarle
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Power Solutions International Poised for 75% Upside
- What is a Secondary Public Offering? What Investors Need to Know
- Why Wall Street Is Betting on These 3 Comeback Stocks
- How to Most Effectively Use the MarketBeat Earnings Screener
- Smart Investors Are Watching These 3 Undervalued Stocks
Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.